Cargando…
Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
INTRODUCTION: Metastatic involvement of at least one nonregional lymph node currently renders patients with esophageal cancer as having stage IV disease. However, the management and outcomes of patients whose sole determinant of stage IV status is nonregional lymph nodes (abbreviated as “stage IV-no...
Autores principales: | Zhan, Peter L., Canavan, Maureen E., Ermer, Theresa, Pichert, Matthew D., Li, Andrew X., Maduka, Richard C., Kaminski, Michael F., Boffa, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700291/ https://www.ncbi.nlm.nih.gov/pubmed/36444359 http://dx.doi.org/10.1016/j.jtocrr.2022.100426 |
Ejemplares similares
-
Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
por: Zhan, Peter Lee, et al.
Publicado: (2022) -
Association of Insurance Status and Extent of Organ Involvement With Survival Among Patients With Stage IV Cancer
por: Zhan, Peter L., et al.
Publicado: (2022) -
Influence of Nonregional Lymph Node Metastasis as a Prognostic Factor in Metastatic Prostate Cancer Patients
por: Cho, Seok, et al.
Publicado: (2012) -
Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US
por: Ermer, Theresa, et al.
Publicado: (2022) -
Evaluation of gastroesophageal reflux disease and hiatal hernia as risk factors for lobectomy complications
por: Kaminski, Michael F., et al.
Publicado: (2022)